Literature DB >> 16782976

Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.

T Suzuki1, G Masaki, S Ogawa.   

Abstract

BACKGROUND: The purpose of this study was to compare neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
METHODS: In total, 15 each of normal weight (18.5<or=BMI<25), overweight (25<or=BMI<30) and obese (BMI>or=30) patients were enrolled. Anaesthesia was induced and maintained with fentanyl, propofol and nitrous oxide. Neuromuscular block was induced with vecuronium 0.1 mg kg(-1) on the basis of the patient's real body weight (RBW) and was monitored using acceleromyographic train-of-four (TOF) of the adductor pollicis. All patients received neostigmine 0.04 mg kg(-1) combined with atropine 0.02 mg kg(-1) at 25% recovery of the first twitch (T1) of TOF and were allowed to recover to a TOF ratio of 0.9.
RESULTS: The time from administration of vecuronium to spontaneous recovery of T1 to 25% of control was significantly longer in the obese [mean (SD, range); 68.4 (16.3, 39.8-110.8) min] and the overweight groups [49.3 (6.2, 39.8-60.8) min] as compared with the normal weight group [41.0 (9.0, 27.5-59.5) min]. The times for facilitated recovery with neostigmine to a TOF ratio of 0.7 did not differ among groups. However, the recovery to a TOF ratio of 0.9 in the obese [25.9 (6.7, 13.5-41.0) min] and the overweight groups [14.6 (7.7, 3.3-28.5) min] were significantly longer than that in the normal weight group [6.9 (2.0, 3.0-10.7) min].
CONCLUSIONS: Early reversal after neostigmine is prompt; however, recovery to a TOF ratio of 0.9 is slow in overweight and obese patients when vecuronium is dosed on the basis of the patient's RBW.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782976     DOI: 10.1093/bja/ael142

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

1.  Sugammadex: An Update.

Authors:  Tiberiu Ezri; Mona Boaz; Alexander Sherman; Marwan Armaly; Yitzhak Berlovitz
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

Review 2.  Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations.

Authors:  A Thorell; A D MacCormick; S Awad; N Reynolds; D Roulin; N Demartines; M Vignaud; A Alvarez; P M Singh; D N Lobo
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

3.  Anesthetic Pharmacology and the Morbidly Obese Patient.

Authors:  Jerry Ingrande; Hendrikus Jm Lemmens
Journal:  Curr Anesthesiol Rep       Date:  2012-12-13

4.  Sugammadex allows fast-track bariatric surgery.

Authors:  Michele Carron; Stefano Veronese; Mirto Foletto; Carlo Ori
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

Review 5.  Peri-operative Medication Dosing in Adult Obese Elective Surgical Patients: A Systematic Review of Clinical Studies.

Authors:  Zahid Hussain; Colin Curtain; Corinne Mirkazemi; Syed Tabish Razi Zaidi
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 2.859

6.  Comparison of neostigmine induced reversal of vecuronium in normal weight, overweight and obese female patients.

Authors:  Shilpa Bhimasen Joshi; Ks Vasudeva Upadhyaya; M Manjuladevi
Journal:  Indian J Anaesth       Date:  2015-03

7.  Efficacy and Safety of Sugammadex versus Neostigmine in Reversing Neuromuscular Blockade in Morbidly Obese Adult Patients: A Systematic Review and Meta-Analysis.

Authors:  Yamini Subramani; Jill Querney; Susan He; Mahesh Nagappa; Homer Yang; Ashraf Fayad
Journal:  Anesth Essays Res       Date:  2021-08-30

Review 8.  A review on the anesthetic management of obese patients undergoing surgery.

Authors:  Rimanatou Seyni-Boureima; Zongze Zhang; Malyn M L K Antoine; Chrystal D Antoine-Frank
Journal:  BMC Anesthesiol       Date:  2022-04-05       Impact factor: 2.217

9.  Residual Curarization and Postoperative Respiratory Complications Following Laparoscopic Sleeve Gastrectomy. The Effect of Reversal Agents: Sugammadex vs. Neostigmine.

Authors:  Tiberiu Ezri; Shmuel Evron; Irina Petrov; Pinhas Schachter; Yitzhak Berlovitz; Mordechai Shimonov
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05

10.  Dose-reversal effect relationship of three different doses of neostigmine in obese patients: A randomised clinical trial.

Authors:  Satyen Parida; Venkatesan Kausalya; Sandeep Kumar Mishra; Sethuramachandran Adinarayanan
Journal:  Indian J Anaesth       Date:  2017-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.